Recent advances in mesalamine colonic delivery systems

Garrett W, Howitt M (2019) Methods of treating inflammatory bowel disease and parasite infection. U.S. Patent Application No. 16/074,934.

Zeeshan M, Ali H, Khan S, Khan SA, Weigmann B (2019) Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. Int J Pharm 558:201–214

Ham M, Moss AC (2012) Mesalamine in the treatment and maintenance of remission of ulcerative colitis. Expert Rev Clin Pharmacol 5(2):113–123

Desai SA, Kale R (2019) Method development and validation of mesalamine in pharmaceutical dosage form: a review. Int J Pharma Biol Sci Arch 7(3)

Badhana S, Garud N, Garud A (2013) Colon specific drug delivery of mesalamine using eudragit S100-coated chitosan microspheres for the treatment of ulcerative colitis. Int Current Pharma J 2(3):42–48

Sonu I, Lin MV, Blonski W, Lichtenstein GR (2010) Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease. Gastroenterology Clinics 39(3):559–599

Peppercorn MA (1984) Sulfasalazine: pharmacology, clinical use, toxicity, and related new drug development. Ann Intern Med 101(3):377–386

Dahl J, Gray MJ, Bazopoulou D, Beaufay F, Lempart J, Koenigsknecht MJ et al (2017) The anti-inflammatory drug mesalamine targets bacterial polyphosphate accumulation. Nature Microbiol 2(4):1–5

Kar N (2019) Formulation Design and Characterization of Colon-targeted Mesalamine Microspheres and their Biodistribution Potential Study in Mice. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm 12(04).

Kumar M, Kaushik S, Saini V, Kumar C, Bhatt S, Malik A et al (2018) Formulation development and evaluation of colon targeted beads of mesalamine. J Drug Des Res 5(2):1067

Amidon S, Brown JE, Dave VS (2015) Colon-targeted oral drug delivery systems: design trends and approaches. Aaps Pharmscitech 16(4):731–741

Mehta R, Chawla A, Sharma P, Pawar P (2013) Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system. J Adv Pharm Technol Res 4(1):31–41

Brunner M, Greinwald R, Kletter K, Kvaternik H, Corrado M, Eichler H et al (2003) Gastrointestinal transit and release of 5-aminosalicylic acid from 153Sm-labelled mesalazine pellets vs. tablets in male healthy volunteers. Aliment Pharmacol Ther 17(9):1163–1169

Layer PH, Goebell H, Keller J, Dignass A, Klotz U (1995) Delivery and fate of oral mesalamine microgranules within the human small intestine. Gastroenterology 108(5):1427–1433

Lichtenstein G, Kamm M (2008) 5-aminosalicylate formulations for the treatment of ulcerative colitis–methods of comparing release rates and delivery of 5-aminosalicylate to the colonic mucosa. Aliment Pharmacol Ther 28(6):663–673

Yang LP, McCormack PL (2011) MMX® Mesalazine. Drugs 71(2):221–235

Lawlor G, Ahmed A, Moss AC (2010) Once-daily mesalamine granules for ulcerative colitis. Expert review of clinical immunology 6(4):521–526

Rasmussen S, Bondesen S, Hvidberg E, Hansen SH, Binder V, Halskov S et al (1982) 5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans. Gastroenterology 83(5):1062–1070

Wang X, Zhang Q (2012) pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs. Eur J Pharm Biopharm 82(2):219–229

Dangi AA, Divya J (2013) Formulation and evaluation of colon targeted drug delivery system of Levetiracetam using pectin as polymeric carrier. J App Pharma Sci 3(1):78

Singh A, Sharma A (2014) Novel approaches for colon targeted drug delivery system. Int J Res Dev Pharmacy Life Sci 3(2):877–886

Mirabbasi F, Dorkoosh FA, Moghimi A, Shahsavari S, Babanejad N, Seifirad S (2017) Preparation of Mesalamine Nanoparticles Using a Novel Polyurethane-Chitosan Graft Copolymer. Pharma Nanotechnol\ 5(3):230–239

Rehman F, Rahim A, Airoldi C, Volpe PL (2016) Preparation and characterization of glycidyl methacrylate organo bridges grafted mesoporous silica SBA-15 as ibuprofen and mesalamine carrier for controlled release. Mater Sci Eng C Mater Biol Appl 59:970–979

Pawar PK, Gautam C (2016) Design, optimization and evaluation of mesalamine matrix tablet for colon drug delivery system. J Pharma Invest 46(1):67–78

Zhang F (2016) Melt-extruded Eudragit® FS-based granules for colonic drug delivery. AAPS PharmSciTech 17(1):56–67

Patole VC, Pandit AP (2018) Mesalamine-loaded alginate microspheres filled in enteric coated HPMC capsules for local treatment of ulcerative colitis: in vitro and in vivo characterization. Journal of Pharmaceutical Investigation 48(3):257–267

Patil A, Pawar P, Gharge V, Doltade U, Doijad R (2018) Mesalamine-loaded mucoadhesive microsphere for colon drug delivery system: Effect of process variables and in vitro characterization. Int J Pharma Invest 8(2):74–82

Pawar P, Varsha G (2018) Formulation and Evaluation of Mesalamine Loaded pH Dependent Colon Specific Pulsatile Drug Delivery System. Curr Res Pharma Sci:244–253

Parmar C, Parikh K, Mundada P, Bhavsar D, Sawant K (2018) Formulation and optimization of enteric coated bilayer tablets of mesalamine by RSM: In vitro–In vivo investigations and roentogenographic study. J Drug Delivery Sci Technol 44:388–398

Chandrawati R (2016) Enzyme-responsive polymer hydrogels for therapeutic delivery. Exp Biol Med 241(9):972–979

Jin L, Ding YC, Zhang Y, Xu XQ, Cao Q (2016) A novel pH-enzyme-dependent mesalamine colon-specific delivery system. Drug Des Devel Ther 10:2021–2028

Jaiswal M, Lanjhiyana S (2018) Fabrication and Evaluations of Dual Crosslinked Mesalamine containing Pectin-Chitosan gel micro beads for controlled and targeted colon delivery. Res J Pharm Technol 11(11):4797–4804

Kaufman J, Griffiths TA, Surette MG, Ness S, Rioux KP (2009) Effects of Mesalamine (5-5-Aminosalicylic Acid) on Bacterial Gene Expression. Inflamm Bowel Dis 15(7):985–996

Krishnaiah Y, Seetha Devi A, Nageswara Rao L, Bhaskar Reddy P, Karthikeyan R, Satyanarayana V (2001) Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets. J Pharm Pharm Sci 4(3):235–243

Kaur R, Gulati M, Singh SK (2017) Role of synbiotics in polysaccharide assisted colon targeted microspheres of mesalamine for the treatment of ulcerative colitis. Int J Biol Macromol 95:438–450

Thakur V, Singh A, Joshi N, Mishra N (2019) Spray Dried Formulation of Mesalamine Embedded with Probiotic Biomass for the Treatment of Ulcerative Colitis: In-Vitro and In-Vivo studies. Drug Dev Ind Pharm 45(11):1807–1820

Mohanta S, Singh SK, Kumar B, Gulati M, Kumar R, Yadav AK et al (2019) Efficacy of co-administration of modified apple polysaccharide and probiotics in guar gum-Eudragit S100 based mesalamine mini tablets: A novel approach in treating ulcerative colitis. Int J Biol Macromol 126:427–435

Kandula M, Kumar KS, Palanichamy S, Rampal A (2016) Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases. Int Immunopharmacol 40:443–451

Cesar AL, Abrantes FA, Farah L, Castilho RO, Cardoso V, Fernandes SO et al (2018) New mesalamine polymeric conjugate for controlled release: Preparation, characterization and biodistribution study. Eur J Pharm Sci 111:57–64

Walz M, Hagemann D, Trentzsch M, Weber A, Henle T (2018) Degradation studies of modified inulin as potential encapsulation material for colon targeting and release of mesalamine. Carbohydr Polym 199:102–108

Anindya AL, Oktaviani RD, Praevina BR, Damayanti S, Kurniati NF, Riani C et al (2019) Xylan from Pineapple Stem Waste: a Potential Biopolymer for Colonic Targeting of Anti-inflammatory Agent Mesalamine. AAPS PharmSciTech 20(3):112

Souza BS, Marcelino HR, Alexandrino F, Urtiga SC, Silva KC, Soares DC et al (2019) Water-in-Water Emulsion as a New Approach to Produce Mesalamine-Loaded Xylan-Based Microparticles. App Sci 9(17):3519

Schoellhammer CM, Traverso G (2016) Low-frequency ultrasound for drug delivery in the gastrointestinal tract:1045-1048.

Maloney E, Hwang JH (2017) Intra-luminal focused ultrasound for augmentation of gastrointestinal drug delivery. Ann Transl Med 5(7):178

Kost J, Langer RS (1990) Ultrasound enhancement of transbuccal drug delivery. U.S. Patent No 4,948,587.

Sonis S (2017) Ultrasound-mediated drug delivery. Oral Dis 23(2):135–138

Schoellhammer CM, Schroeder A, Maa R, Lauwers GY, Swiston A, Zervas M et al (2016) Low-frequency ultrasound for the delivery of therapeutics to the gastrointestinal tract. J Acoust Soc Am 139(4):2091–2092

Schoellhammer CM, Lauwers GY, Goettel JA, Oberli MA, Cleveland C, Park JY et al (2017) Ultrasound-mediated delivery of RNA to colonic mucosa of live mice. Gastroenterology 152(5):1151–1160